Zantac Lawsuit: Settlement Updates (September 2026)

The Zantac Lawsuit is an ACTIVE Lawsuit

Zantac was one of the most widely used medications in the country for many years. People who suffered from acid reflux and heartburn trusted Zantac to help relieve their symptoms. Unfortunately, thousands of Zantac users have developed cancer over the years, and many people living with cancer have filed product liability lawsuits against the makers of this drug. 

If you used Zantac and have received a cancer diagnosis, read on to learn more about the ongoing litigation and whether you may be eligible to bring a Zantac lawsuit to recover your related losses. 

Click Here to View the Latest Zantac Lawsuit Update

Zantac Lawsuit Table of Contents

Contact the dedicated legal team at Lawsuit Legal News

January 2025 Zantac Lawsuit Update

Even though many Zantac lawsuits have been settled, all eyes will be on California’s Russell v. Boehringer Ingelheim Pharmaceuticals, Inc. We’ll continue to keep you updated as the jury trial progresses.

Stay informed on the latest developments in the Zantac lawsuit as new evidence and court rulings continue to shape the ongoing litigation.

Bookmark this page to continue to get key updates from Lawsuit Legal News.

February 5, 2025: Boehringer Ingelheim Faces Scrutiny in Illinois Trial

A corporate representative from Boehringer Ingelheim took the stand in the Illinois retrial. Her testimony raised some difficult questions about the company’s handling of Zantac’s safety concerns.

During questioning, the Boehringer witness attempted to minimize the significance of the discoloration seen in Zantac pills, dismissing it as a purely visual issue rather than an indicator of potential chemical instability. However, her statements only reinforced suspicions that the company deliberately ignored warning signs instead of investigating the root cause.

Plaintiffs’ attorneys pushed back against the notion that coating the pill was merely a cosmetic adjustment, highlighting internal discussions that suggested Boehringer was aware the discoloration pointed to a more serious chemical problem. The company’s explanation for halting discoloration tests—claiming that prior results showed “consistency”—is deeply concerning. If anything, that suggests the company repeatedly observed a degradation pattern but took no meaningful steps to address it, a troubling and possibly incriminating admission.

Adding to the controversy, Boehringer appears to be trying to deflect responsibility by pointing the finger at GlaxoSmithKline, attempting to distance itself from earlier research on ranitidine’s instability. The claim that no one within the company reviewed pre-2019 studies on the drug’s safety is difficult to believe—especially given that Boehringer employs around 50,000 people. Expecting a jury to accept that no one was tasked with examining critical safety data for a blockbuster medication seems like an exercise in willful ignorance rather than a simple oversight.

As the trial continues, all eyes are on the jury to see whether they will recognize these evasions for what they are and push these cases forward against Boehringer Ingelheim.

February 1, 2025: Zantac Trials

There will likely be a lot of Boehringer Ingelheim Zantac trials in 2025. The first one of 2025 is in Illinois. It is a retrial for two plaintiffs who have accused Boehringer Ingelheim of ignoring decades of warning signs that its over-the-counter Zantac could lead to cancer. Their counsel lawyers told a new jury once again that internal studies and scientific data showed that ranitidine, Zantac’s active ingredient, could break down into NDMA.

The case follows previous mistrials for both plaintiffs. These are prostate cancer claims. The science is strong on these cases but there is definitely less jury appeal. Still, Cook County juries are traditionally very fair to plaintiffs and there is hope for a big verdict."

Following the Glaxo Zantac settlement, additional lawsuits continue to emerge against other companies involved. Just last week, a new case was filed in Delaware by an Arizona resident, alleging that prolonged Zantac use led to their bladder cancer. The lawsuit targets Boehringer Ingelheim Pharmaceuticals, Inc., Sanofi-Aventis U.S. LLC, and Patheon Manufacturing Services LLC, accusing them of developing, producing, promoting, and distributing Zantac and its generic versions without properly informing consumers of the associated health risks."

November 22, 2024 – Another Zantac Trial Ends in Mistrial

A California state court judge ruled a mistrial in a lawsuit against Boehringer involving claims about its Zantac heartburn medication.

The plaintiff, a bladder cancer survivor, accused the company of failing to disclose the drug’s potential cancer risks. After a full week of deliberation, jurors unanimously agreed that Zantac was hazardous and that Boehringer neglected to provide adequate warnings. However, they were evenly divided (6-6) on whether the medication directly played a substantial role in causing the man’s cancer. This deadlock led the judge to declare a mistrial.

While a mistrial isn’t necessarily a victory, this outcome stemmed from a specific question of causation. The jury left no doubt about the company’s negligence in failing to warn consumers about the drug’s dangers.

October 9, 2024 - Glaxo Offers Massive Settlement

On October 9, 2024, a significant settlement regarding Zantac lawsuits was announced. GSK disclosed plans to allocate up to $2.2 billion to settle approximately 80,000 claims. The resolution, set to take effect in 2025, is expected to cover around 93% of the pending cases.

It’s important to note that this settlement pertains solely to GlaxoSmithKline and does not include Boehringer Ingelheim.

October 7, 2024 - Defendants Submit Their Delaware Appeal

Last week, the defendants submitted their brief to the Delaware Supreme Court. They stressed that the MDL judge had already made a decision on this matter. They also cautioned that Delaware might turn into a safe haven for mass tort claims if the lower court's ruling stands.

Their main point is that the plaintiffs' experts couldn't specify an exact dose of ranitidine or NDMA that leads to cancer risk. They also found fault with the use of studies not linked to how people take ranitidine such as NDMA exposure from food or industry. The Delaware trial court saw these issues but brushed them off. It cited Delaware's more relaxed rules for expert testimony and hinted that the MDL judge didn't grasp the science at first.

Plaintiffs claim the MDL's demand for an exact threshold dose creates an unfair obstacle. They argue this requirement throws out their cases by asking for a specific cancer risk number that science hasn't pinned down. They think this strict rule goes against Delaware's method, which looks at wider scientific proof and recognizes how tricky real-world chemical exposure can be.

September 30, 2024 - First Zantac Case in California Goes to Court

Defendants have settled nearly every Zantac lawsuit so far in California. But now, the first Zantac trial in California has kicked off with jury selection today, September 30, 2024; opening statements are expected to begin on October 7. Both plaintiffs and defendants will be watching this case closely since it could reveal a lot about any future Zantac lawsuits to come nationwide. So far, GSK has settled all of their cases, leaving just Boehringer as the last defendant standing. Maybe, they have a trick on their sleeve; maybe they are just misguided, and maybe they are just standing up for themselves in what they believe is a case in which they did nothing wrong. Whatever the reason, we will be watching this one closely.

September 2, 2024 - Delaware Supreme Court Decision Will Have Profound Impact on the Future Zantac Litigation

We still believe there is sound science behind the Zantac cancer risk. However, if the defendant manufacturers are successful in their appeal, this could effectively end Zantac litigation in Delaware. Further, if the Delaware Supreme Court opts to exclude plaintiffs experts, the likelihood of a Zantac settlement in Illinois, Pennsylvania, and Connecticut will become remote.

Zantac attorneys are anxiously awaiting the Supreme Court's decision, which will likely control the fate of all Zantac cases. If the defendant manufacturers are successful, lawsuits in other states will likely meet a similar outcome, and this will preclude the defendants from making any settlement overtures.

August 28, 2024 - Delaware Supreme Court Takes Up Zantac Appeal

The Delaware Supreme Court has agreed to hear an interlocutory appeal in the Zantac lawsuits involving nearly 75,000 plaintiffs who claim Zantac caused them to develop cancers. GSK, Pfizer and Sanofi, have filed this appeal asking the Delaware Supreme Court to overturn a Superior Court's order that allowed plaintiffs to proffer expert testimony that long term use of Zantac can cause cancer.

The appeal follows the Superior Court's decision allowing the plaintiffs' expert testimony on causation to proceed despite the defendants' objections. While the appeal is not ideal for plaintiffs, it's significant that the litigation can continue while the Supreme Court deliberates.

August 23, 2024 - Zantac Litigation Moves Forward in Connecticut

Unlike Florida, Connecticut is emerging as a new battleground for Zantac litigation.

A state court judge has denied motions to dismiss from the major pharmaceutical companies, which will allow the Zantac cancer lawsuits to proceed. The defendants argued the court lacked jurisdiction, but the judge ruled otherwise, mainly because the companies conduct business in the state and they're registered to operate there.

August 20, 2024 - Zantac Experts Rejected in Florida

Florida appears to be a challenging venue for the Zantac lawsuits. A Florida judge has dismissed the expert witnesses for the plaintiff in a prostate cancer case linked to Zantac.

GSK succeeded in a Daubert hearing wherein a Florida state court Judge rejected the plaintiff's general and specific causation experts linking long-term use of ranitidine to prostate cancer.

Daubert is a standard by which a federal court will determine whether expert testimony is admissible in accordance with specific criteria. The criteria include whether the science is whether the scientific premise is accepted in the scientific community, whether the methodology employed in the expert's testing has been subject to peer review, and whether the expert's methods are reliable and were reliably applied to the testing.

Thankfully, Zantac litigation can continue in 49 other states.

We believe the science is much stronger in linking Zantac use to bladder cancer, pancreatic cancer, and stomach cancer than perhaps it is with other cancers.

August 19, 2024 - Third Zantac Lawsuit Trial Ends in a Hung Jury

A Cook County jury could not come to an agreement and the case of Martin Goss ended in a mistrial. Martin alleged prolonged use of Zantac caused his prostate cancer. The plaintiffs' Zantac lawyer stated he would try this lawsuit again. We believe the plaintiff's prostate cancer was caused by Zantac use, and this will be proven in the subsequent trial. 

We have not drawn any conclusions on Zantac cancer claims based on the last two trials. We felt the science connecting colorectal cancer to be weak, and the link between Zantac and prostate cancer is extremely strong and will be ferreted out in future trials. 

August 7, 2024 - Zantac Lawsuit Goes Down in Flames in Illinois Trial

A Cook County jury (Illinois State Court) determined that Carrie Joiner could not pin liability for her colorectal cancer against GSK. Boehringer Ingelheim settled their claim prior to trial. This is the second Zantac lawsuit trial in a row to end in a defense verdict. 

We believe the science linking Zantac to colorectal cancer is weak at best, and we still feel confident in prostate cancer, bladder cancer, liver cancer, and stomach cancer claims. We believe any Zantac cancer lawsuit is highly dependent on the science, and ultimately, the above-referenced defendants are going to settle only the strongest claims and remain highly skeptical of the others.

Zantac lawyers remain highly confident in lawsuits pending in Delaware and Pennsylvania as well. A number of upcoming trials concerning prostate, liver, and bladder cancer will determine the fate of this lawsuit.

There are 70,000 Zantac cases pending in Pennsylvania and Delaware. 

July 24, 2024 - Third Illinois Zantac Lawsuit Trial Underway

The third Zantac trial is now underway in Chicago (Cook County), wherein the plaintiff developed prostate cancer after taking Zantac OTC for years to treat his heartburn. Plaintiff Martin Goss alleges Boehringer Ingelheim (defendant manufacturer) ignored internal studies and observations that ranitidine was breaking down and degrading into a dangerous carcinogenic chemical known as NDMA.

Another Zantac trial that started last week is presently underway five floors down. The outcome of these two trials could determine the fate of thousands of cases pending in Illinois, along with over 70,000 Zantac claims pending in Delaware. We are now two years removed from a federal judge in Florida dismissing the Zantac multidistrict 

July 18, 2024 - Second Zantac Cancer Lawsuit Trial Begins in Chicago

Another Zantac trial begins in Cook County. GlaxoSmithKline and Boehringer Ingelheim are defending the second Zantac cancer lawsuit to proceed to trial. Plaintiff Carrie Joiner claims to have unwittingly used a heartburn drug contaminated with a human carcinogen for 15 years prior to being diagnosed with colorectal cancer in 2021.

Zantac lawyers for Carrier Joiner allege that her physician was unaware of the dangers ranitidine (the active ingredient in Zantac) posed to humans and that GSK failed to perform any testing for NDMA in over forty years. The first Zantac trial ended in a defense verdict. Zantac attorneys remain confident in proving up bladder cancer, stomach cancer, and prostate cancer claims going forward.

Attorneys for the defendant manufacturers allege that plaintiff's colorectal cancer is not causally related to long term Zantac use and point to a bevy of epidemiological studies that provided conflicting findings.

July 15, 2024 - July Update on Zantac Lawsuits Moving to State Courts and New Settlements

A significant development in the Zantac MDL occurred in June 2024, when a Delaware state court judge ruled that Zantac lawsuits could proceed to jury trials.

As a result of this court ruling in Delaware, the focus of Zantac litigation is gradually shifting from the federal MDL to state courts. And with California also moving forward with state cases, Delaware and California are expected to become focal points for ongoing Zantac lawsuits.

Sanofi and Pfizer Settlement

A major pharmaceutical company involved in the Zantac litigation, Pfizer, has reached a settlement agreement that encompasses over 10,000 lawsuits from the allegations of cancer risks linked to Zantac use.

In a separate development, Sanofi, one of the manufacturers of Zantac, also reached a settlement agreement to resolve approximately 4,000 lawsuits outside of Delaware on behalf of Zantac plaintiffs.

These settlements signify a substantial step forward in the resolution of the legal claims against the pharmaceutical companies.

These decisions marked a crucial turning point for the federal cases. Due to the aforementioned settlements and other factors, the number of active cases within the Zantac MDL has experienced a significant decline. The number of cases has dropped from over 14,000 in June to around 2,400 in July 2024.

We anticipate more Zantac settlements as litigation continues to progress in Delaware, Pennsylvania and Illinois.

June 3, 2024 - Delaware Court Allows Zantac Lawsuits to Proceed to Jury Trials

Delaware's Superior Court Judge Vivian Medinilla issued a new ruling that breathes new life into nationwide Zantac lawsuits. The judge ruled that the evidence provided by plaintiffs who allege they developed various forms of cancer after using Zantac is credible and sufficient to allow their personal injury cases to proceed to trial. This means approximately 75,000 cases will have their day in court against the heartburn medication manufacturers, including GlaxoSmithKline, Pfizer, and Boehringer Ingelheim, if they are not settled first.

Although the drug manufacturers will likely appeal the decision, this ruling is a tremendous victory for thousands of Zantac users who thought their chances to receive compensation were lost after the federal Multi-district Litigation was dismissed in March.

March 29, 2024 - Federal Court Decision Pushes Cases to State Courts

The federal court's decision on the Zantac lawsuit marked a major turning point in the litigation. Really, it ended it. The judge overseeing the case, Judge Rosenberg, ruled in favor of the defendants and, with that ruling, brought the federal aspect of the lawsuit to a close. This decision sparked discussions and analyses among lawyers and legal analysts over emails, phone, social media, and definitely in person. The ruling was quite a shock since the science seemed sound, and it looked like the Zantac manufacturers would be held responsible.

Here is what you need to know about that crucial decision and how it has impacted the Zantac lawsuit and the people who allege the drug injured them.

Illinois Jury Sides with Boehringer Ingelheim in Zantac Prostate Cancer Lawsuit—What It Means for You

For years, Zantac was a go-to medication for heartburn relief. But when researchers discovered that its active ingredient, ranitidine, could break down into NDMA, a chemical linked to cancer, everything changed. Thousands of people who had taken the drug for years began filing lawsuits, arguing that it played a role in their cancer diagnoses. 

Recently, an Illinois jury ruled in favor of Boehringer Ingelheim, one of the companies that manufactured Zantac. The case involved two men who claimed the drug caused their prostate cancer and that the company failed to warn consumers about the risks. While this verdict is a setback for some plaintiffs, it doesn’t mean the fight is over. Many other Zantac lawsuits are still moving through the courts, especially those involving different types of cancer. 

If you’ve taken Zantac and been diagnosed with cancer, this decision might leave you with more questions than answers. Does this affect your case? Are other Zantac lawsuits still moving forward? And what should you do next? Here’s what you need to know.

Background on Zantac and the NDMA Controversy 

Zantac served as a common remedy for heartburn and acid reflux for years. Folks could buy it over the counter or get it through a prescription, and they took it without worry. However, everything changed in 2019 when scientists found that ranitidine, the main ingredient in Zantac, could break down to form NDMA, a chemical linked to cancer.

How NDMA Became a Concern 

The issue first came to light when Valisure, an independent lab, tested ranitidine and found extremely high levels of NDMA—sometimes thousands of times above what the FDA considers safe. Unlike many drug recalls, this wasn’t caused by contamination during manufacturing. Rather, researchers found that ranitidine itself was unstable and could decompose to form NDMA over time.

The bigger problems? 

- Storing Zantac at high temperatures, like in a car or warehouse, could speed up the process. 

- NDMA could also form inside the body after someone took the medication. 

This suggested that regular Zantac users may have exposed themselves to harmful levels of a likely cancer-causing substance.

After reviewing the findings, the FDA pulled all Zantac and ranitidine products from the market in April 2020. This recall applied to both prescription and over-the-counter versions, leaving millions of former users wondering if their health had been put at risk. 

Since then, thousands of lawsuits have been filed by people who took Zantac and were later diagnosed with cancers like bladder, stomach, liver, pancreatic, and colon cancer. They claim that drug makers ignored the dangers and didn't warn customers.

Why This Still Matters 

The Zantac legal fight continues in courts nationwide. Though some cases have been thrown out, others progress in state courts. These lawsuits mean more than just money to long-term Zantac users who got cancer later. They aim to make drug makers answer for not alerting the public to risks.

The Claims Against Boehringer Ingelheim 

Boehringer Ingelheim, one of the companies involved in the manufacturing of Zantac, is facing a lot of legal heat. The claims against them revolve around the idea that the company knew about the risks of NDMA contamination in Zantac but didn’t do enough to warn consumers. 

One of the main claims is that Boehringer knew ranitidine, Zantac's active ingredient, could degrade into NDMA—a possible cancer-causing substance—particularly when heated or stored for long times. Even with this knowledge, the company kept making and selling the drug without changing its warnings or telling consumers how to store it to avoid NDMA formation.

Also, plaintiffs say Boehringer overlooked clear indications from studies and internal reports hinting that Zantac might harm its users. They argue that the company put profits before public health by skipping proper safety checks and not informing the FDA about growing concerns.

Boehringer Ingelheim’s Defense 

Boehringer Ingelheim has fought back against the lawsuits, claiming it shouldn't bear responsibility for the Zantac allegations. The company's main argument rests on two points: it didn't create the drug, and the FDA had already decided on the necessary safety warnings before Boehringer started manufacturing it.

The company also points out that NDMA is a common impurity found in many foods, water, and even other medications. Boehringer argues that the levels found in Zantac weren’t proven to be high enough to cause harm under normal use. They state that while they manufactured Zantac, they adhered to all safety rules and didn't discover any signs of harmful NDMA contamination.

Another main argument is that the FDA has the responsibility of setting drug labeling regulations. Boehringer maintains that it followed all rules when it owned Zantac and shouldn't face blame for any supposed failure to alert consumers.

Even with these safeguards in place numerous plaintiffs claim that independent laboratory testing found high NDMA concentrations in Zantac—in some cases far above FDA-approved limits. Although Boehringer insists it took all the necessary precautions, the legal dispute continues, and the courts will determine if the company should bear responsibility.

The Verdict and Its Impact on Future Zantac Cases 

The Illinois jury's choice to back Boehringer Ingelheim marked a significant point in the current Zantac legal battles. The two plaintiffs who stated Zantac led to their prostate cancer faced a harsh defeat. But how will this outcome shape the path for others who've started legal proceedings—or those thinking about taking legal steps?

To start off, keep in mind that this verdict only applies to this particular case. The ruling doesn't mean all Zantac lawsuits will end the same way. This case centered on prostate cancer, while many other lawsuits involve different cancer types such as bladder, stomach, and liver cancer. Each case stands on its own, and a loss in one trial doesn't mean others won't succeed.

Still, drug makers will use this verdict to claim there's not enough scientific proof linking Zantac to prostate cancer. On the flip side, plaintiffs’ attorneys will continue to push forward, presenting new evidence in other trials. 

For anyone considering legal action, this verdict is a reminder that these cases aren’t simple. Some will face more challenges than others, but the legal fight isn’t over. Plenty of lawsuits are still working their way through the legal system, and a few might end up in settlements or victories for those suing. If you suspect your cancer diagnosis has a connection to Zantac, reaching out to a lawyer can help you decide on your next steps.

Speak With a Zantac Attorney Today

If you took Zantac and later developed cancer, you might be wondering what your options are. While some lawsuits have faced setbacks, many are still moving forward, especially for cancers like bladder, stomach, and liver cancer. The fight isn’t over, and there’s still a chance to seek compensation.

A lawsuit won’t change what’s happened, but it can help ease the financial burden of medical bills, lost income, and other costs. More importantly, it sends a message that drug manufacturers need to be held accountable when they put people’s health at risk.There are deadlines for filing a claim, so waiting too long could mean missing your opportunity. Talking to a lawyer is free, and you don’t pay anything unless your case is successful. If you think Zantac may have played a role in your diagnosis, now is the time to get answers. Reach out today to see if you qualify.

Are There Reasons Why a Zantac Lawyer Might Decline a Case?

Yes. Some of those reasons include:

  • Your case is impossible to prove. If you can’t verify the extended use of ranitidine, a diagnosis of an NDMA-linked illness, or the link between the two, your lawyer may not accept your case. Your attorney, however, may have additional suggestions for how to prove one of these elements, particularly the use of over-the-counter Zantac, for which you do not have receipts.
  • Your damages are not large enough to make pursuing the case worthwhile for you or the attorney. Certain medical conditions that ranitidine-containing products have caused will not result in enough expenses to warrant the cost of litigation. However, the majority of illnesses associated with NDMA exposure are both life-threatening and life-altering in nature.
  • The lawyer does not have the time or resources to devote to your case. The cost of pursuing damages in this type of case is extraordinary, but the lawyer incurs these expenses unless you recover compensation.
Illinois Jury Sides with Boehringer Ingelheim in Zantac Prostate Cancer Lawsuit

Reexamination of the Evidence Kills Federal Zantac Lawsuit

At the heart of Judge Rosenberg's ruling was their examination of the evidence presented by the plaintiffs. The judge concluded that the methodologies used by the plaintiffs' expert epidemiologists weren't reliable.

The judge's decision was largely made up by the plaintiffs' selective use of different studies and data that only supported their case and left out science that contradicted their case. More or less, they "cherry-picked" the evidence, and the judge found that they did it in a way that was beyond acceptable.

In fact, the cherry-picking of the Zantac evidence has raised concerns about evidence standards in health-related litigation that may affect other cases.

Overall, the Zantac lawsuit was an extremely complicated legal matter. The ruling put a spotlight on how legal standards are handled in procedures like the Daubert hearing, which plays a crucial role in determining which scientific evidence will be allowed at trial. And since the standards of a Daubert hearing differ from state to state, the federal lawsuit outcome showed how these nuances can greatly impact litigation of large pharmaceuticals and health-related lawsuits as state-based cases all come together into one federal case.

Although the federal court has made its decision, the legal battle still has some hope in the state courts. Each state has its own laws and legal standards, meaning that cases in state courts could get different results. The Zantac class action lawsuit will not proceed in state court.

This independence has caused there to be coordinated litigation efforts which basically amount to "mini-Multi-District Litigations" (MDLs) in states like California, Pennsylvania, and Delaware.

Update on California Zantac Mini MDL

California appears to be moving forward with state-based Zantac lawsuits. The dismissal of the federal class action lawsuits has led more plaintiffs to pursue claims in state courts. With Zantac's manufacturers agreeing to several confidential settlements recently, it seems the defendants are willing to settle to avoid trials. Hopefully, this is a sign that the defendants want to just close out these state cases now that they have dodged the proverbial 'federal bullet'. Both parties and the court in California are finalizing the trial dates for the next round of Zantac trials.

Update on Delaware Zantac Mini MDL

Delaware's state-based Zantac lawsuits have recently gone through a Daubert hearing. This hearing will determine whether the scientific evidence and expert testimony will be accepted by Judge Medinilla So far, no ruling has been issued yet. Obviously the outcome will be important for how the lawsuits in Delaware will play out.

Update on Pennsylvania Zantac Mini MDL

There isn't really any new information on the status of Pennsylvania's state-based Zantac lawsuits. We are waiting to hear more.

Continue to follow Lawsuit Legal News to stay informed about legal proceedings of the Zantac lawsuits. For now, it looks like whatever Zantac cases will survive will be in state court and there is a slim chance that the federal MDL will be appealed. As information becomes available, we will continue to provide timely updates and insights into the Zantac lawsuits.

zantac cancer link

Over 2,000 individuals joined a multi-district litigation (MDL) lawsuit in the United States Federal Court system against the manufacturer of Zantac. This widely used medication contained ranitidine, an antihistamine, and an antacid used to treat heartburn. 

The Status of Zantac Cancer Lawsuits

The plaintiffs claim that the makers of Zantac misled millions of consumers into "purchasing and ingesting a defective, misbranded, adulterated and harmful drug" while neglecting to disclose that the drug contained a probable human carcinogen called N-nitrosodimethylamine, or NDMA.

The initial Zantac lawsuit was filed after statements and actions by the Food & Drug Administration (FDA), which tested the product for the presence of NDMA. Sanofi finally voluntarily recalled the drug in the U.S. and Canada. 

Regrettably, the federal MDL was dismissed a few months ago. Since then, injured Zantac users have now filed state-level lawsuits in Pennsylvania, Delaware, and California.

Zantac Recall Timeline

  • More than 15 million people in the U.S. have been affected by the Zantac recall
  • October 2, 2019, FDA finds unacceptable levels of NDMA in ranitidine products
  • October 8, 2019, GlaxoSmithKline removes brand name Zantac from the market
  • October 18, 2019, Sanofi recalls Zantac in Canada and U.S.
  • November 1, 2019, FDA announces NDMA testing of 18 different ranitidine products contained NDMA levels up to 2.85ppm.
  • December 4, 2019, FDA recommends manufacturers halt products if they contain unacceptable levels of NDMA
  • In March 2020, more than fifteen U.S. manufacturers recalled their heartburn medications from the market, including
    • American Health Packaging
    • Amneal Pharmaceuticals LLC
    • Apotex Corp. (Rite-Aid, Walmart, and Walgreen brands)
    • Appco Pharma LLC
    • Aurobindo Pharma USA
    • Denton Pharma (d.b.a. Northwind Pharmaceuticals)
    • Dr. Reddy’s Laboratories LTD (CVS, Kroger, Target, Walmart, and Walgreen brands)
    • Glaxo SmithKline
    • Glenmark Pharmaceuticals Inc.
    • Golden State Medical Supply Inc.
    • Lannett Company Inc.
    • Novitium Pharma LLC
    • Perrigo Company PLC
    • Precision Dose Inc.
    • Sandoz
    • Sanofi (brand-name Zantac)
  • April 1, 2020, the FDA announced an immediate Zantac recall and market withdrawal of OTC and prescription ranitidine products.

If you were diagnosed with cancer after taking Zantac between 1983 and 2020, it is essential to consult with experienced Zantac lawsuit attorneys as soon as possible. If you developed bladder cancer or stomach cancer, your claim is especially strong. A dedicated dangerous drug attorney can explain how to file a claim and request damages for the financial losses and life impacts you have suffered after taking Zantac.

Do I Qualify to Bring a Zantac Lawsuit?

An experienced product liability lawyer associated with Lawsuit Legal News can help determine whether you qualify for a Zantac lawsuit during a free consultation.

The general criteria include:

  • You regularly used Zantac or another generic drug containing ranitidine daily for at least three months.
  • You've been diagnosed with cancer in one of the areas associated with Zantac use, such as your digestive tract or in your blood.
  • There was a latency period between starting Zantac use and your cancer diagnosis of at least one year. The specific timeframe required depends on your type of cancer diagnosis.

Contact the dedicated legal team at Lawsuit Legal News

How Experienced Attorneys Can Assist With Your Zantac Cancer Claim

The skilled attorneys affiliated with Lawsuit Legal News have extensive experience in Zantac lawsuits and are working with affected individuals throughout the United States. These attorneys have a strong national network of leading lawyers across the country who provide the best service for injured clients. They also offer local counsel services for out-of-state clients.

Zantac cancer lawsuits are not the only dangerous product cases these attorneys handle. The team is also pursuing other product liability claims against defective medications and products, including:

These dedicated lawyers are also targeting sex trafficking and sexual abuse claims nationwide.

Other dangerous product cases the Lawsuit Legal News attorneys have pursued include:

Elmiron

This prescription medication, used to treat bladder pain, has been linked to eye and vision problems, including:

  • Difficulty reading
  • Dark spots appearing in the sufferer's vision
  • The inability to adjust quickly to less light
  • Blurred vision

The experienced LLN attorneys have investigated hundreds of Elmiron claims.

Mesothelioma

The attorneys associated with LLN have also been active in mesothelioma cases. Mesothelioma is a rare but highly aggressive form of cancer caused by exposure to asbestos. The disease is not curable, and those who receive this diagnosis generally have a life expectancy of about 12 months. 

LLN legal professionals have:

  • Thoroughly investigated many claims
  • Assisted clients suffering medical issues or their family members in gathering important evidence
  • Relied on their network of experts to assist with the testimony necessary to prove claims related to this illness
  • Filed lawsuits on behalf of their asbestos-exposed clients
  • Assisted clients with workers' compensation claims 

What Is Zantac?

What Is Zantac?

Ranitidine hydrochloride, more commonly known as Zantac, was invented by Glaxo Holdings, Ltd, and received its first FDA approval in 1983 for short-term use in treating a common form of ulcers. When the FDA approved Zantac, it was already reviewed and approved in 31 other countries. Within five years, Zantac became the best-selling drug in the world and one of the first to ever generate more than $1 billion in annual sales.

Zantac belongs to a category of drugs called H2 blockers. These medications were created to reduce the amount of stomach acid. Zantac's prescription-only version was meant to treat:

  • Stomach and intestinal ulcers and stop new ulcers from forming
  • Erosive esophagitis
  • Gastroesophageal reflux disease (GERD)
  • A digestive disorder called Zollinger-Ellison Syndrome which causes pancreatic and small intestine tumors

For those who didn't need a prescription-strength formula, the maker created a milder version of Zantac that was available over-the-counter to treat heartburn and other issues caused by acid indigestion.

Zantac Usage Instructions and Side Effects

The labeled instructions for Zantac noted that the user should take the medication orally and either with food or without. Recommended usage was once or twice a day, though some individuals were prescribed to take it up to four times a day. The most common side effects of Zantac mentioned were headaches, constipation, or diarrhea.

However, patients were warned to seek medical attention immediately for more serious side effects, such as:

  • Blurred vision
  • Mental or mood changes, such as agitation, confusion, depression, or hallucinations
  • Easy bleeding or bruising
  • Enlarged breasts
  • Severe tiredness
  • Fast, slow, or irregular heartbeat
  • Signs of infection, such as a sore throat, fever, or chills
  • Severe abdominal pain
  • Dark urine
  • The yellowing of the skin or eyes, known as jaundice

When Was Zantac First Linked to Cancer?

When Was Zantac First Linked to Cancer?

Although the medications containing ranitidine hydrochloride were extremely successful and popular, researchers found problems nearly immediately. In 1983, two Italian studies linked ranitidine to NDMA. The studies also found that Zantac contains dimethylamine (DMA), and when that is combined with nitrosamines, nitrites, and nitrates in common foods like grilled meats, it creates NDMA, which can cause damage to the cellular DNA of the cells in the human gastric system.

This damage could mutate DNA strands and create cancer cells in certain cases. As a result of these findings, investigators recommended that Zantac be taken without food, and the user could take Vitamin C, to help prevent cancer creation. 

Apparently, the drug manufacturers ignored these warnings.

 When Glaxo's ranitidine patent expired in 1997, other drug manufacturers rushed to join the success party by producing generic versions. In 2004, Zantac was approved for over-the-counter use. Sanofi became the manufacturer of Zantac in 2017, and the drug was widely available along with all the generic forms.

The FDA finally paid attention to the concern about NDMA levels in Zantac recently, as it investigated the effect of NDMA in other medicines, including blood pressure and heart failure medications. Eventually, the FDA officials recommended voluntary drug recalls, including other medicines containing NDMAs, such as Zantac. Experts now believe NDMA is likely a human carcinogen.

What types of Zantac cancers have been identified?

Several types of cancers have been linked to ranitidine ingestion, including cancers of the: 

  • Liver 
  • Esophagus 
  • Throat 
  • Stomach 
  • Bladder 
  • Kidney 
  • Breast 
  • Uterus 
  • Ovaries 
  • Testicles 
  • Prostate 
  • Thyroid 
  • Small Intestine 
  • Colon  
  • Rectum 

Blood cancers such as leukemia and non-Hodgkin's lymphoma may also be associated with the use of ranitidine-containing products.

Liver Cancer

The liver is a football-sized organ that sits in the upper right portion of your abdomen. There are several types of liver cancer, including the more common type that is spread to the liver from other parts of the body, as well as those that begin in the cells within the organ itself.

Some of the symptoms of liver cancer include:

  • Losing weight without trying.
  • Loss of appetite.
  • Upper abdominal pain.
  • Nausea and vomiting.
  • Overall body weakness and fatigue.
  • Abdominal swelling.
  • Yellow discoloration of the skin or whites of the eyes.
  • White, chalky stools

Stomach or Colorectal Cancer

As explained by the American Cancer Society, cancer begins when cells begin growing out of control in one part of the body. These cancerous cells can then spread to other organs. Stomach cancer, also known as gastric cancer, is caused when the cell overgrowth begins in the stomach.

This type of cancer generally forms over years. The five-year relative survival rate for this type of cancer is five years, meaning that when compared to people with similar types of cancer who were diagnosed at the same stage and the general population, 70 percent of individuals diagnosed with stomach cancer will still be alive five years after diagnosis.

The stages of cancer are generally:

  • Stage 1: The cancer is localized to one organ in the body. This stage presents the best survival rate.
  • Stage 2: The cancer cells spread to other organs in the same region of the body where cancer started.
  • Stage 3: The cancer cells spread throughout the body.

Colorectal cancer starts in the colon or rectum. Most colorectal cancers start with a small growth in the colon or rectum known as a polyp. There are many different types of polyps and not all of them result in the formation of cancer. Those most likely to cause cancer include polyps that are larger than 1 cm, and several polyps occurring in the same general area simultaneously.

Breast Cancer

The link between H2 blocker medications like ranitidine and breast cancer was established in a 2008 study. The study revealed that the drug increases the risk of ductal carcinoma by more than two-fold in both men and women. One of the first Zantac lawsuits involved a Florida man who was diagnosed with breast cancer in 2013. At the time of the diagnosis, he had been using Zantac for about four years to treat regular heartburn.

Ductal carcinoma is the most common type of breast cancer, accounting for around 20 percent of all new breast cancer cases. 180,000 women are diagnosed with invasive ductal carcinoma each year, and this condition can also affect men.

Bladder Cancer

Bladder cancer most often begins in the cells that line the inside of the bladder. Because most bladder cancers are detected and diagnosed early, this condition is considered highly treatable.

The symptoms of bladder cancer include:

  • Blood in the urine, which may cause urine to appear bright red or cola-colored.
  • Frequent urination.
  • Painful urination.
  • Frequent backaches.

Because the function of the kidneys is to filter harmful chemicals from the bloodstream and move them to the bladder for elimination from the body, cancer-causing chemicals are a frequent suspect in the cause of this type of cancer. Bladder cancer occurs more frequently in men than it does in women.

Small Intestine Cancer

Cancer of the small intestine is a rare disease that occurs when cancer cells form in the tissues of the small intestine. This type of cancer generally presents with abdominal pain and unexplained weight loss. The small intestine is part of the body’s digestive system, along with the esophagus, stomach, and large intestine. The digestive system works to remove and process nutrients from the foods we eat while also helping to pass waste material from the body.

This type of cancer is generally diagnosed following an exam that includes:

  • A complete physical exam and medical history.
  • Blood chemistry studies that measure the level of certain substances in the body. An amount of these substances that is higher or lower than normal indicates the need to further consider a diagnosis of small intestine cancer.
  • Tests that study the liver function. Higher amounts of a certain substance in the liver can indicate a condition that results from small intestine cancer.
  • An endoscopy, which is a diagnostic test in which the organs and tissues are studied using an internal camera to look for abnormal areas.
  • A biopsy, which is another diagnostic test in which cells from the affected area are studied under a microscope to look for abnormalities.

The survival rate of small intestine cancer depends on several factors, including whether the cancer has spread to other organs, including the liver.

Esophageal Cancer

The esophagus is a long, hollow tube that runs from the throat to the stomach, helping to move food from the mouth to the stomach for digestion. Esophageal cancer generally begins with cancerous cells growing in the lining of the esophagus. More prevalent in men than women, this type of cancer can appear in any part of the esophagus and the risk—as with most types of cancers—is that the abnormal cells will spread through the blood or lymph system to other parts of the body.

Signs and symptoms of esophageal cancer include:

  • Difficulty swallowing.
  • Weight loss without trying.
  • Chest pain, pressure, or burning.
  • Worsening indigestion or heartburn.
  • Coughing or hoarseness.

Those who have gastroesophageal reflux disease, known as GERD, are at higher risk of developing this type of cancer. GERD is one of the issues that Zantac was designed to treat.

Prostate Cancer

The prostate is a gland only found in males, and it is responsible for producing some of the fluid that is part of semen. Prostate cancer begins when the cells in the prostate gland begin to grow uncontrollably. The most common type of prostate cancer is adenocarcinoma. However, there are several other types of prostate cancer as well. Most prostate cancers grow very slowly, though some can grow and spread rapidly.

The symptoms of prostate cancer include:

  • A painful or burning sensation during urination or ejaculation.
  • Sudden erectile dysfunction.
  • Blood in the urine or semen.
  • Frequent urination, particularly at night.
  • Difficulty stopping or starting urination.

Pancreatic Cancer

The pancreas is an organ located in the abdomen, in the lower part of the stomach. This organ is responsible for releasing enzymes that aid in digestion, as well as hormones that help to regulate blood sugar. The most common type of pancreatic cancer forms in the cells that line the ducts that carry digestive enzymes out of the pancreas. Pancreatic cancer often does not present with any discernible symptoms during the early stages, which is one of the main reasons why this cancer is not usually diagnosed while it is in a stage where treatment will be effective.

Advanced pancreatic cancer shows symptoms such as:

  • Abdominal pain that radiates down the back.
  • Loss of appetite or unintended weight loss.
  • Yellowing of the skin or the whites of the eyes.
  • Light-colored stools.
  • Dark-colored urine.
  • Itchy skin.
  • A new diagnosis of diabetes, or pre-existing diabetes that becomes harder to control.
  • Blood clots.
  • Fatigue.

Ovarian Cancer

The female reproductive system contains two ovaries, located on each side of the uterus. The almond-sized ovaries produce eggs as well as the hormones estrogen and progesterone, which control the female reproductive cycle. Ovarian cancer is often undetected until after it has already spread to other organs in the abdomen.

The symptoms of ovarian cancer include:

  • Abdominal bloating or swelling.
  • Quickly feeling full when eating.
  • Weight loss.
  • Discomfort in the pelvic area.
  • Changes in bowel habits, including constipation.
  • A frequent need to urinate.

As with many types of cancers, treatment can include surgery and chemotherapy.

Uterine Cancer

Also known as endometrial cancer, uterine cancer begins in the uterus, which is a hollow, pear-shaped organ responsible for fetal development. Uterine cancer is often detected early, as it presents with abnormal vaginal bleeding. Generally, if the cancer has not spread to other organs, removal of the uterus can cure endometrial cancer.

Throat Cancer

Throat cancer can appear in the throat (pharynx), voice box (larynx), or tonsils. This type of cancer often begins in the flat cells that line the throat.

Symptoms of throat cancer can include:

  • A cough.
  • Changes in the voice, particularly hoarseness.
  • Ear pain.
  • Difficulty swallowing.
  • A lump or sore that doesn’t heal.
  • A sore throat.
  • Weight loss.

Like esophageal cancer, the risk of developing throat cancer is increased among individuals with GERD.

Testicular Cancer

Testicular cancer occurs in the testes of men. The testes are located inside the scrotum and produce hormones and sperm needed for reproduction. While relatively rare when compared to other types of cancer, testicular cancer is actually the most common cancer to occur in American males between the ages of 15 to 35. This type of cancer is generally highly treatable, even if it has spread beyond the testicle.

Symptoms include:

  • A lump or enlargement in either testicle.
  • A feeling of heaviness in the scrotum.
  • A dull ache in the abdomen or groin.
  • A sudden collection of fluid in the scrotum.
  • Pain or discomfort in the testicle or scrotum.
  • Enlargement of the breasts.
  • Back pain.

Thyroid Cancer

The thyroid is an organ shaped like a small butterfly that is located in the lower front region of the neck. Not only does this organ control the metabolism, it also releases hormones that direct bodily functions, including how you use energy, produce heat, and consume oxygen. Thyroid cancer also seldom produces symptoms until it has progressed.

Symptoms of thyroid cancer include:

  • Neck or throat pain.
  • A lump in the neck.
  • Vocal changes, such as hoarseness.
  • Cough.

Thyroid cancer generally responds well to treatment, even if it is more advanced when initially detected.

Other Ranitidine Cancers

Other cancers are potentially associated with ranitidine or Zantac use. If you were diagnosed with cancer and you used Zantac or other products containing ranitidine and would like more information about whether you qualify to participate in the Zantac lawsuits and receive compensation for expenses and impacts related to your illness, contact us as soon as possible.

So What Is NDMA?

N-Nitrosodimethylamine (NDMA) is a yellow liquid with no odor. It was originally created to be rocket fuel, but that ended after regulators discovered that this dangerous substance was contaminating the soil, air, and water near the rocket manufacturing plant. Currently, NDMA is only used for research purposes in the U.S.

Regardless of the regulations controlling the use of the substance, we've learned that NDMA can be inadvertently made when certain chemicals react during some industrial processes. Also, small amounts of NDMA can be found in food and other products consumed by humans. This is the primary way most people are exposed to the substance.

Food and other products that commonly contain NDMA include:

  • Tobacco, including smoking and chewing tobacco
  • Cured meats, including bacon
  • Beer
  • Fish
  • Cheeses
  • Bathroom and cosmetic products such as shampoos and cleansers
  • Vehicle interior air
  • Household goods, including cleaning supplies and pesticides
  • Baby bottles and pacifiers made from rubber
  • Human breast milk
  • Municipal water supplies

We now know that NDMA can be formed in the human stomach during digestion, especially in foods containing alkylamines, which are naturally occurring compounds in various foods and drugs. NDMA can also enter the body through breathing air containing the substance, though NDMA usually dissipates quickly when airborn.

Experiments have indicated that after animals have ingested NDMA, it quickly enters the bloodstream and several body organs. When the substance finally reaches the liver, it becomes other substances that can leave the body within a day, usually through exhalation and normal elimination processes.

The federal Emergency Planning and Community Right-to-Know Act of 1986 (EPCRA), classifies NDMA as "extremely hazardous." Under  this Act, stringent reporting requirements apply to people and companies that produce, store, or use NDMA in large amounts because it is a probable human carcinogen. Medical experts also worry about how NDMA contamination can affect the human body.

How the FDA Has Responded to Zantac Cancer Concerns

The FDA finally addressed Zantac concerns during the fourth quarter of 2019. Here's a summary of the FDA statements and corresponding actions:

September 13, 2019: The FDA announced that laboratory tests revealed low levels of NDMA in products containing ranitidine. The agency began evaluating whether low levels of NDMA in ranitidine posed a risk to patients who used medications containing this substance. The FDA did not recommend patients using ranitidine stop taking their medication. It did urge those patients to talk with their medical provider about alternative treatment options and report any adverse reactions to the FDA's MedWatch website.

September 24, 2019: The FDA announced a voluntary recall of 14 lots of generic prescription ranitidine capsules because NDMA was found in the drug. The agency stated that not all ranitidine-containing products had been recalled, and the FDA continued its investigation of ranitidine. Also, companies and regulators must follow a new testing protocol to detect the NDMA levels in ranitidine products.

September 26, 2019: Just two days later, the FDA announced the voluntary recall of over-the-counter ranitidine products produced by Apotex Corp and labeled by Walmart, Walgreens, and Rite Aid.

October 23, 2019: Almost a month later, the FDA announced more voluntary recalls, including Sanofi's over-the-counter drug Zantac and ranitidine products sold by Dr. Reddy's Laboratories, LTD.

October 28, 2019: More recalls of ranitidine products were announced, including products from Perrigo Company, Novitium Pharma LLC, and Lannett Company.

November 1, 2019: The FDA disclosed laboratory results from testing multiple ranitidine-containing products. The lab results showed NDMA levels similar to those commonly found in foods such as grilled meats. Although the NDMA levels were lower than in earlier studies, they were still higher than acceptable by agency standards. The agency's patient instructions did not change.

November 8, 2019: The FDA announced another recall, this time related to Aurobindo Pharma USA. The FDA advised all ranitidine product manufacturers to also recall their products and perform their own laboratory tests following the agency's testing protocol to ensure that the levels of the NDMA were not unacceptably high.

November 12, 2019: Two more voluntary recalls were announced. The new targets were products manufactured by Amneal Pharmaceuticals and American Health Packaging.

November 22, 2019: Even more voluntary recalls affected products manufactured by Golden State Medical Supply and Precision Dose Inc.

December 4, 2019: An FDA statement urged manufacturers to continue testing their ranitidine-containing products for unacceptable levels of NDMA. Products containing more than 96 nanograms per daily dose or 0.32 parts per million of the substance are considered unacceptable.

December 2019 to February 2020: Several companies voluntarily recalled their products because they contained more than the acceptable amount of NDMA.

April 1, 2020: The FDA ordered all ranitidine-containing over-the-counter products to be removed from the market immediately. Through further testing, the agency found the level of NDMA in these products increased over time when the product was stored at higher than room temperature. The tests also suggested  NDMA could increase when the product is stored for longer periods of time, even at room temperature. Finally, the FDA announced no new over-the-counter or prescription products containing ranitidine would be available for medical use.

Many products containing nizatidine were also recalled because they contained unacceptable levels of NDMA. Similar to ranitidine, nizatidine was a drug used to treat stomach ulcers and was also approved to treat occasional heartburn and acid indigestion. 

So far, the FDA has not detected unacceptable levels of NDMA in other medications used to treat the same conditions, such as:

  • Famotidine (Pepcid)
  • Cimetidine (Tagamet)
  • Esomeprazole (Nexium)
  • Lansoprazole (Prevacid)
  • Omeprazole (Prilosec)

The FDA was also concerned about the potential harm animals may suffer if given products containing ranitidine. The agency urged companies that manufacture animal drugs to also test their products.

Recalled Zantac Brands

Numerous ranitidine brands have removed their products from store shelves and homes. For an up-to-date list, you can view the FDA’s recalls page.

These brands removed their products in advance of the FDA’s required recall:

  • American Health Packaging
  • Amneal Pharmaceuticals
  • Aurobindo Pharma USA
  • Apotex Corp
  • Appco Pharma
  • Denton Pharma
  • Reddy’s Laboratories
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Golden State Medical Supply
  • Lannett Company
  • Novitium Pharma
  • Perrigo Company
  • Precision Dose
  • Sandoz
  • Sanofi

If you or a loved one has taken any of these brand name drugs, or any other ranitidine drug, you could be at serious risk of developing cancer due to your exposure to NDMA. If this applies to you, speak with your doctor right away. Your doctor can help you identify a new medicine that can help with your heartburn and also help determine your risk of cancer.

After you have spoken with your doctor, it’s important to speak with a skilled product liability lawyer who can help you recover maximum compensation from the negligent party. You may have astronomical medical bills ahead, and you should not have to bear any of that responsibility. Holding the negligent party liable for your injuries and your suffering can help ease the financial pain you may face. To do that, you need to file a product liability claim with the help of an experienced lawyer.

What are the Potential Risks of Long-Term NDMA Exposure?

According to the FDA, humans exposed to higher levels of NDMA over a long period of time face a risk of harm. However, people with NDMA levels at or below the acceptable daily intake for a long time would not experience a higher risk of developing cancer.

Despite the Italian tests indicating high levels of NDMA in ranitidine in the 1980s, the FDA claims it does not know how long Zantac has contained high impurity levels. The agency assures it is constantly evaluating already-approved medications to learn more about the safety of those products over time.

If you have been diagnosed with cancer and have used ranitidine drugs such as Zantac, the team of knowledgeable attorneys that supports Lawsuit Legal News can answer your questions and provide more information about your legal options.

Zantac Cancer and Liability Claims

Zantac Cancer and Liability Claims

Under product liability laws, injured individuals can bring a claim against a negligent company to recover legal damages. A successful claim must show how the company designed, manufactured, or marketed the product in a way that caused others harm. 

To bring a Zantac lawsuit, you would need to show that the drug was designed in a way that harmed users and that the manufacturers knew or should have known of the increased risk of cancer caused by the excessive amounts of NDMA in the medication.

Another possible legal theory involves a design defect claim alleging the drug was not created to minimize foreseeable risks to users. Also, you might be able to bring a marketing defect claim, which usually involves a failure to warn of known dangers. For example, if the manufacturer knew NDMA was likely to increase users' cancer risk but did not warn them, it may face liability for resulting injuries.

You may also have the grounds to bring a negligence claim, depending on your situation. In a negligence claim, you must prove that the manufacturer acted negligently or failed to act reasonably under the circumstances and that those actions or inactions harmed you.

For example, if a manufacturer knew NDMA was in its drug but failed to perform adequate studies to determine if users would suffer any adverse side effects, these actions could constitute negligence.

If you and your lawyer can establish the manufacturer's liability, bringing a Zantac lawsuit can help you collect compensation to cover your losses. The LLN team understands that financial compensation will not take away your cancer. However, it will help you receive the best medical care possible while allowing you to focus on your health and recovery instead of worrying about how you will pay for the medical treatment you need.

Seeking Compensation After Zantac Use: The Process

After a cancer diagnosis related to Zantac use, filing a personal injury claim can provide you with the compensation you need to pay your medical bills, keep up with your regular expenses, and continue to maintain your personal and financial independence.

Contact an experienced personal injury attorney for more information about how to file a lawsuit and what it means for you.

Free Consultation

Start by sitting down with an attorney for a free consultation regarding your claim. During that first consultation, an attorney can provide you with valuable answers that can help guide you as you decide what comes next. That free consultation can also offer you an opportunity to decide whether you want to work with a specific attorney or if you would prefer to seek out another law firm for your needs.

During your free consultation, you will:

  • Go over your diagnosis and Zantac use. To file a claim, you will need to show that you used Zantac over a period of time and that you have a diagnosis linked to that Zantac use. An attorney will look at the evidence of your diagnosis, including your medical records and any information provided by your doctor.
  • Assess what other information you need. To file a personal injury claim, you will need to provide a wealth of information and evidence. During your free consultation, an attorney can take a look at the evidence you already have and assess what more you need to file your personal injury claim.
  • Give you an idea of the compensation you deserve and your options for seeking it. Many people, especially those who have never been through a personal injury claim before, may have little idea of how much compensation they can actually receive for a claim. Your Zantac use may give you grounds for a considerable personal injury claim, depending on your diagnosis, the extent of your medical bills, and your overall suffering related to the diagnosis. An attorney can help look over your claim and give you a better idea of how much you should expect.
  • Get a feel for the attorney and what that law firm can offer you. During your free consultation, you may want to go over factors like how the attorney prefers to communicate, what fees he will take, whether you can file your claim on a contingent fee basis, and how your attorney will handle the case. You may also want to ask about the attorney’s experience, including past claims they have worked on of this nature.

The Investigation

Once you choose an attorney and the attorney decides to take your claim, you will start working on your personal injury claim. It starts with an investigation: collecting any evidence regarding your claim. In the case of a Zantac-related claim, this may include your medical bills and medical records, which will establish how much you have had to pay as a result of a cancer diagnosis related to Zantac use. Your attorney may also want other evidence about how your diagnosis has impacted other areas of your life: missed opportunities or friendships that came to an end, for example.

The research already exists that shows Zantac’s potential link to cancer, especially stomach and intestine-related cancers. Your attorney will cite that research as part of the reason for your claim.

The Demand Package

After reviewing the evidence related to your claim, your attorney will put together a demand package that covers the funds you expect to receive for your claim. Your demand package will include an assessment of your claim, including how much you expect to receive in compensation, as well as evidence of your Zantac use and cancer diagnosis.

Your attorney will include an assessment of your medical expenses, your lost wages, and your pain and suffering related to Zantac use and a diagnosis that followed. Most demand packages include pain and suffering as a percentage of your medical expenses. Talk to your attorney to learn more about what gets included in your Zantac claim demand package.

Negotiation

Once you submit your demand package, Zantac has a chance to respond. Zantac’s lawyers have already had time to prepare for their response to a personal injury claim. They may have already decided how much they want to offer you as you file your claim. Chances are, it will not reflect the amount you feel that you deserve in compensation for your suffering.

An attorney can help you decide whether to accept a settlement offer or continue to negotiate. In many cases, you may go through multiple rounds of negotiation before arriving at a satisfactory agreement.

Court

If you cannot reach an agreement through negotiation, your attorney will recommend taking your claim to court. Carefully discuss your options to discover whether this offers the right choice for you. Most personal injury claims, including medication liability claims, settle out of court.

Payment

Once you reach an agreement or obtain a favorable judgment, you will receive payment for your suffering related to taking Zantac. Most of the time, unless designated otherwise in the agreement, Zantac will have thirty days to submit payment.

Zantac Cancer FAQ

At this point, you may have serious questions about what comes next. You may wonder whether you took Zantac long enough to risk getting cancer. You may not know if your risk has increased. You may also be unsure of how you will pay all of the medical expenses you face.

Even if you do not have cancer, which would obviously be wonderful news, tests can prove extremely costly, and your insurance may not cover them. To find out you don’t have Zantac cancer, you could end up paying out of your own pocket. You shouldn’t have to do that.

By working with a product liability lawyer with experience suing drug manufacturers, you can try to collect damages against the at-fault party. By exposing you to excessive amounts of NDMA through Zantac, your increased risk of exposure means that you could recover financial compensation for your medical expenses and pain and suffering.

Surely, no amount of money will erase everything you have been through or magically make everything better, but the money will allow you the opportunity to focus all of your effort and energy on your health and well-being.

If you or a loved one has taken Zantac and now may have cancer, you need to speak with a product liability lawyer as soon as possible. Your ability to recover may depend on the lawyer you choose.

Does Zantac cause cancer?

This is a loaded question, but ultimately, it’s the question everyone is trying to answer. Thus far, the evidence seems to suggest that Zantac does indeed cause cancer. Whether it’s the FDA, the WHO, or the nation’s leading universities, the resounding consensus is that NDMA is a cancer-causing chemical that is found at alarming rates in Zantac and generic ranitidine brands.

However, this does not mean that Zantac itself was manufactured in a way that created contamination during the making of the pill. That is a fine legal distinction. The high levels of NDMA found in Zantac come from ranitidine, the key ingredient. This means the drug is defective by design. Remember, one reason for liability is negligent manufacturing or negligent design. The studies we have cited suggest that Zantac’s design is defective because of its use of ranitidine.

Should I stop taking Zantac?

Yes, immediately. You should stop taking any drug that contains ranitidine. Upon issuance of the FDA mandate to stop selling and prescribing Zantac, your doctor’s office should have contacted you to stop taking the drug and to schedule a visit as soon as possible.

If you have not heard from your doctor, you should still stop taking Zantac immediately. You should also schedule an appointment with your doctor to discuss what other heartburn medication you may benefit from, so you can continue to ease that pain and discomfort. You also want to discuss what to do next to make sure that you do not have cancerous cells in your body after taking Zantac.

Some people mistakenly believe that if they reduce their dosage of Zantac, that will be safe. Unfortunately, because of the extremely high levels of NDMA found in Zantac and ranitidine, no one should take any level of dosage of these medications.

Will I get Zantac cancer?

That is a question for you and your doctor to explore. However, we can tell you that based on the studies conducted, that taking even one Zantac pill increases a user’s risk of getting cancer.

This happens because of the NDMA in ranitidine and how it exposes your body to extremely high levels of contamination. There is no guaranteed formula to determine whether you will get cancer due to your use of Zantac. What we do know, however, is that taking Zantac increases your risk and means that you should take immediate action by speaking with your doctor as soon as possible.

Can I take a different heartburn drug?

Thankfully, modern medicine does not put all of its heartburn relief eggs in one basket. As a frequent sufferer of heartburn, you have the option to take other medications that have not shown any connection to cancer.

These include:

  • Nexium
  • Pepcid
  • Prevacid
  • Prilosec
  • Tagamet

All of these drugs have been tested for NDMA, and none show any signs of contamination. This is good news for you, as some of these drugs are available over the counter. No matter what, you want to get advice and consultation from your doctor to make sure you are taking the right steps to reduce and potentially eliminate your heartburn without putting yourself at risk of cancer.

You also must make sure that you are not suffering from Zantac cancer. Make sure you get tested and take the appropriate action to keep yourself healthy.

Who is liable?

This is a complex legal question that your lawsuit will attempt to answer. From the evidence we have so far, Zantac and generic ranitidine manufacturers may have known about the potential cancer risks dating back to the 1980s. Your chosen legal representative will try to make the case that the drug manufacturer knew of the risk, chose to ignore the risk, promoted the drug regardless of the risk, and that you took the drug to alleviate your heartburn—only to end up with cancer.

This is a tragic scenario that could have been avoided had the drug manufacturer acted appropriately. That’s why you should bring a claim. It’s an opportunity to hold the at-fault party accountable for its mistakes and for your pain and suffering.

If you retain Dolman Law Group Accident Injury Lawyers, PA, we will attempt to establish that the drug company put profits over users’ safety.

To strengthen your case, we will try to prove:

  • The drug company did not adequately research the drug and its long-term consequences.
  • The drug company knew or should have known of the drug’s risk of cancer.
  • The drug company failed to act after it became aware of the link between NDMA and cancer.

By making this case, we can help you maximize your ultimate compensation. That money will help pay for your physical recovery. You should not have to worry about your finances during this extremely challenging time in your life. Bringing a claim against the negligent party can take the stress and burden of mounting medical bills off your shoulders, allowing you the time necessary to focus on your health.

Have lawsuits already been filed?

Yes, many. To date, over 100 lawsuits have been brought against Zantac manufacturers, including Sanofi. The Judicial Panel on Multidistrict Litigation has merged these cases under one United States District Court based in Miami, Florida.

While the court has consolidated these cases, that does not prevent other lawsuits from coming forward, including yours. Furthermore, just because these cases have been consolidated in Florida, does not mean that you have to reside in Florida to bring a claim. This merger was done simply for judicial expediency. If you reside or have been harmed anywhere in the country, then you can bring a Zantac cancer lawsuit. We can help.

Do I qualify for a Zantac class action lawsuit?

Individuals who can prove that they purchased Zantac may qualify to join a class action lawsuit. By joining a class action, you do not have to prove that you have suffered harm. In other words, you do not have to prove that you have Zantac cancer.

Joining a class action allows you to simply show that you purchased Zantac or a generic brand of ranitidine and that you were not warned about the risk of cancer. There is also power in numbers. Joining a class action speaks volumes simply by the number of victims in the class.

Will my case join a class action?

You don’t necessarily have to join a class action to pursue justice. Ultimately, this is a calculated legal decision that will likely depend on the amount of damages that you or your family have suffered.

If you or a loved one took Zantac and was subsequently diagnosed with cancer, you could file a personal injury claim against the manufacturer and/or store that sold you the drug. This path is best for victims who have unfortunately been diagnosed with cancer, as it allows for the largest amount in damages. By filing a personal injury claim, you can attempt to recover maximum compensation for your injuries and your suffering.

What damages may I collect?

This question largely depends on the details of your case. If you have joined a class action and have not suffered from cancer, you likely don’t qualify to pursue significant compensation. If you bring a personal injury claim, however, you may receive more compensation.

You can expect your lawyer to try to collect certain damages for you, including:

  • Pain and suffering
  • Emotional distress
  • Lost wages
  • Lost earning potential
  • Loss of companionship
  • Loss of life enjoyment
  • Present and future medical bills
  • Rehabilitation costs

Every moment of suffering could increase your potential financial recovery. That’s why it is important to discuss your options with a trusted personal injury lawyer as soon as possible. You want to speak with a lawyer who has experience taking on big drug companies. At Dolman Law Group Accident Injury Lawyers, PA, we have that experience.

Should I settle?

Settlement is always an option during the claims process. However, remember this extremely important point: the insurance or drug company offering you a settlement does not have your best interests at heart.

Insurance companies are in the business of making money. If they pay out the full value of your claim, that cuts into their profits. When an insurance company offers you a quick settlement, you should treat it with caution. The insurance company knows you are suffering, knows you want to put this behind you, and hopes that you do not yet have legal representation.

When you work with a knowledgeable Zantac cancer attorney, you can lean on his or her years of experience and guidance. Your lawyer may tell you that the amount the insurance company offers is too low. He or she will determine this by creating an accurate estimate of your total financial needs. Instead of simply calculating the medical bills you see sitting on your kitchen table, you need to also account for all of your future needs and more subjective damages.

For example, you may face:

  • Extended hospital stays
  • Long periods of time out of work or an inability to return to your occupation
  • Multiple surgeries
  • Prescription drug costs
  • Multiple doctor visits
  • In-facility rehabilitation
  • In-home care

Each of these items comes with extreme financial burdens. Your family members may feel the burden to take on extra work to help cover the financial losses of you being out of work. That is not their burden to bear.

What’s more, if you sign a settlement offer, you will waive your right to bring any future claims against the insurance company. In practice, this means that months or years later, your settlement funds could run out, and if you still have medical expenses to cover, there is nothing you can do to seek additional compensation.

That’s why it is vital to the success of your recovery that you work with a trusted Zantac cancer lawyer. Your legal representative will have your best interests at heart and will work tirelessly to maximize your compensation.

Will my case go to trial?

We know that many people fear trial. Going to trial adds time to your recovery and can result in additional stress during an already stressful time. In many cases, we only take a case like yours to trial if the insurance company refuses to settle for a fair and reasonable amount. When this happens, sometimes the mere threat of a trial is enough to make the insurance company raise its settlement offer. No matter what, we want to be prepared for trial, just in case.

While it is true that most personal injury and product liability claims settle out of court, there is still a possibility that your case will go to trial. That’s why, when choosing the right lawyer for your Zantac cancer lawsuit, you should choose a legal team with drug company trial experience. At Dolman Law Group Accident Injury Lawyers, PA, we will do everything we can to settle your case without going to trial, but if you have a lawyer at your side who has trial experience, that will help push the insurance company toward a faster and larger settlement.

We also do not want to be surprised at trial, so we will begin preparing for trial right away, even as we work diligently and aggressively to settle your claim.

My pet has been taking a medication that contains ranitidine. What should I do about it?

The FDA has expressed concern that pets may suffer the same effects of NDMA found in ranitidine as humans do. Therefore, talk to your veterinarian about alternative medications to treat your pet.

How do I dispose of my unused Zantac?

If you can’t return the drug to the store or pharmacy where it was purchased due to COVID-19 precautions or other logistical issues, you should follow safe disposal directions provided in the manufacturer’s label or follow these steps offered by the FDA:

  • Mix liquid or pill medications with an unappealing substance such as dirt or cat litter.
  • Place the mixture in a sealed plastic bag.
  • Dispose of the mixture in your household trash.
  • Be sure to delete all of your information from the prescription label and throw away or recycle the packaging.

Will Zantac ever return to the market?

It is unclear if ranitidine will be available by prescription or over-the-counter in the future. The FDA states that the companies manufacturing this drug must prove that the drug does not contain dangerous levels of NDMA—even after time or in less-than-optimal storage conditions—for it to be approved for use.

What constitutes “regular” use of Zantac?

While the specific criteria for Zantac lawsuit eligibility continue to develop, a good rule of thumb for determining if your use of Zantac was regular is to determine if you took the medication daily for at least three months.

Does Zantac have to pay my medical bills if I face a cancer diagnosis because of my Zantac use?

No, Zantac does not have to pay your medical bills directly after a cancer diagnosis, even a diagnosis linked to your Zantac use. Many victims believe that a Zantac-related cancer diagnosis, or another diagnosis caused by the negligence of another party, will get paid for by the party that caused their illness.

A personal injury claim does not work that way. Following any type of diagnosis, you will take responsibility for your medical expenses until you can secure a settlement or court award. If you cannot afford to pay for your medical bills, you do have some options that can help you take care of those payments. You can choose to:

Use your health insuranceYour health insurance will pay for many of the expenses associated with a cancer diagnosis following your Zantac use. Consult your health insurance provider to learn more about what coverage you have. You may need to ask questions about:

  • Your deductible. Your deductible represents the expenses you will need to pay yourself before your insurance kicks in.
  • Your copays. Many health insurance companies require the insured individual to pay for a percentage of any medical service you receive. You may have a flat fee for some expenses, like appointments with your doctor, and a variable fee for others. For example, you may have to pay a set percentage of any surgical bills, rather than having a flat fee.
  • What your insurance company will cover with regards to durable medical equipment. With a cancer diagnosis, you may need to modify your home or use durable medical equipment to help you get around when you feel weak and unsteady on your feet. You may want to ask about what equipment your insurance company will cover and what you need to do to receive coverage for anything you need.
  • What coverage your insurance company offers for in-home care. Many cancer patients prefer to stay at home if they can, rather than receiving all of their treatments in the hospital directly. You may, however, need assistance or even skilled nursing care to make it possible for you to stay at home. Consult your insurance provider to learn more about what coverage they offer.
  • Your out-of-pocket maximum. Most insurance companies will set a maximum amount that you will have to pay out-of-pocket each year. Consult your insurance provider to learn more about how much you will have to pay out-of-pocket each year. Keep in mind that this will represent an annual amount, so if you have cancer treatments that span more than a year, you may need to budget for future years’ expenses.

Ask your hospital about what payment options it has available. Many hospitals and cancer centers will work with you so that you can receive the treatment you need even if you cannot pay upfront for that treatment. Consult your hospital to learn about your options. Teaching hospitals, in particular, often offer discounts for people who cannot otherwise afford their services. You may also work out a payment arrangement that will allow you to continue treatments while you work out a way to pay for them. Consult with your care team as soon as possible so that you can adapt your payment schedule as needed.

Get help. Several programs can help you seek help paying for cancer-related expenses. Consult your local cancer care center or hospital to learn more about what programs are available in your area. Often, these programs can also help you cover other bills you may find yourself facing as you juggle cancer treatments.

Hope Lodge and the Healthcare Hospitality Network, for example, offer lodging assistance to individuals and families who need to travel to receive cancer treatment. Your state may offer assistance with in-home caregiver expenses. Your attorney may have a list of the organizations that can assist you while you undergo cancer treatment.

Let your care team know that you have a lawsuit in progress. Consult with your care providers and let them know that you have filed a lawsuit against Zantac, and that you intend to use some of the settlement funds to pay for your medical bills. Your attorney may issue a letter of protection that can help you continue to receive medical care while the lawsuit remains ongoing.

Five Steps to Maximize Your Recovery

You can play a part in your ability to recover compensation for your suffering. There are many things you can do to help increase your financial recovery.

By taking the steps below into consideration, you will play an integral role in your ability to recover.

  1. Keep receipts. To prove that you have suffered damages from taking Zantac or other ranitidine pills, you must first show that you purchased those drugs. Keeping your receipts will show with certainty that you purchased these drugs.
  2. See your doctor. Even if you took Zantac for a short time, and even if you do not show any signs or symptoms of cancer, studies indicate that taking just one ranitidine pill is enough to increase your risk of cancer. Because of this, speak with your doctor about your medical condition. Your doctor can give you a complete evaluation and decide whether you need to undergo further testing. You also want to see your doctor regularly following the initial visit, as the cancer caused by Zantac may not show up immediately. In fact, it could take years for you to detect your cancer. Even before you’re aware that you have cancer, it’s already taking its toll on your health and body. That’s why it is so important to get regular checkups. Early cancer detection is the best way to beat cancer.
  3. Keep medical records. Just like keeping receipts, retain copies of your medical records, starting with any prescriptions from your doctor. While Zantac is available over the counter, if your doctor prescribed Zantac, you want to have that information. You also want diagnosis records. If you have been diagnosed with Zantac cancer, having those records on hand will help prove that you suffered injuries at the hands of the drug manufacturer.
  4. Keep a journal. All of this started because you had heartburn. It’s important to remember that you now face a life-threatening condition because of a non-life-threatening condition. That’s part of what makes Zantac cancer so tragic, and that’s also why keeping a journal can help establish your level of suffering. Keep notes about how you feel every day. Note what hurdles you face and how you overcome them (or fail to overcome them). Note your progress and your setbacks. Note what additional medication or procedures you’ve endured, and don’t forget to keep track of your mental health. Discuss openly and truthfully how you feel, because your mental health is just as important as your physical health. By keeping these notes in a journal, you provide first-hand knowledge of your progress, or lack thereof, and give your chosen legal representation intimate insight into the suffering you face. Your journal may help to increase the amount of compensation you recover from the negligent party.
  5. Contact an experienced attorney. Remember that you do not have to face this alone. Your experienced legal team will work hard to help you maximize your compensation. We will aggressively fight to protect your rights by standing up to the big drug companies and their massive legal teams. We have done it before, and we can do it again.

Settling your case may seem like the best option, and it often is, but only after your lawyer has reviewed the settlement offer. You might think that you can collect more money without a lawyer, because you do not have to pay the lawyer. Unfortunately, that is a mistaken belief. Your best chance of collecting a fair amount is with an experienced lawyer at your side.

The first offer you receive from the insurance company is almost always not its best offer. Remember that the insurance company is not looking out for your best interests. That’s why you need a lawyer at your side who is aggressively fighting to protect your rights and maximize your compensation.

Can I pursue compensation from the maker of Zantac without an attorney?

As a practical matter, no. Consider the expense and complexity of filing a lawsuit against a multi-billion-dollar pharmaceutical company. The manufacturers of this dangerous drug will undoubtedly have legal counsel working to defend them against the labyrinthine issues in this product liability case. You will need your own lawyer to protect you.

Your attorney can provide you with valuable services in the process of recovering compensation, including:

  • Guidance as to your legal options.
  • Experience with MDLs and product liability cases.
  • The timely filing of all court-required paperwork for your case in the proper jurisdiction.
  • A determination of the value of your case based on the economic and non-economic impacts you have suffered as a result of your illness.
  • The collection and organization of evidence that can prove the link between your use of ranitidine and your diagnosis.
  • Skilled negotiation on your behalf to obtain a settlement that will provide you with fair compensation.
  • Attendance at all pre-trial hearings.
  • Instead of a settlement, litigation of your case in court.
  • Assistance collecting your award or settlement.
  • Further representation of your case if the defendants choose to appeal.

After you and your doctor have determined the best path for your medical treatment, speaking with the experienced Zantac lawsuit attorneys at LLN is essential. They aim to work hard to protect your best interests every step of the way. 

You deserve to work with skilled lawyers who have prior experience challenging big drug companies and showing how their negligent actions harm victims like you. By taking action and filing a state Zantac lawsuit against the drug company, you can begin the process that will help you recover damages for your injuries. 

Don't hesitate to seek legal guidance from the Lawsuit Legal News team if you have been diagnosed with cancer after using ranitidine drugs or Zantac. Our experienced attorneys can provide more information about your legal options and help you navigate the complex process of holding drug manufacturers accountable for their negligence. Contact us today.

Matthew Dolman, Esq.
Legally Reviewed by

Matthew Dolman, Esq.

Founding Partner • Dolman Law Group Accident Injury Lawyers, PA National Civil Trial Attorney

Matt Dolman is a civil trial attorney with more than two decades of experience litigating complex claims nationwide. His work includes cases involving serious injury, defective products, and institutional liability. He is known for a disciplined approach to case strategy and a deep understanding of how large defendants and insurers evaluate risk. Dolman Law Group has secured more than $700 million in recoveries for clients. Matt is recognized by Super Lawyers, Florida Legal Elite, and Best Lawyers, and is a Lifetime Member of both the Million Dollar and Multi-Million Dollar Advocates Forums.

Florida Bar Member in Good Standing